Shareholders of Warnex Approve the Amalgamation With Diagnos
27 Junio 2014 - 10:41AM
Marketwired
Shareholders of Warnex Approve the Amalgamation With Diagnos
BROSSARD, QUEBEC--(Marketwired - Jun 27, 2014) - DIAGNOS Inc.
("DIAGNOS") (TSX-VENTURE:ADK), a leader in healthcare technical
services including, screening, software and algorithm development,
data analysis, and image processing, is pleased to announce that,
at an annual and special meeting of the shareholders (the
"Meeting") of Warnex Inc. ("Warnex") held yesterday, June 26, 2014,
the shareholders of Warnex approved the terms of the amalgamation
(the "Amalgamation") with a wholly-owned subsidiary of DIAGNOS
initially announced on May 5, 2014. The Amalgamation was approved
by 99.95% of Warnex shareholders voting in person or by proxy at
the Meeting.
Closing of the Amalgamation is expected to occur on July 8,
2014.
About
DIAGNOS
Founded in 1998, DIAGNOS is a publicly traded Canadian
corporation, with a mission to commercialize technologies combining
contextual imaging and traditional data mining thereby improving
decision making processes. DIAGNOS offers products, services, and
solutions to clients in a variety of fields including healthcare
and natural resources.
Forward-looking
information
This document contains forward-looking information. There can be
no assurance that forward-looking information will prove to be
accurate, as actual results and future events could differ
materially from those anticipated in these statements.
For further information on DIAGNOS, please visit our website at
www.diagnos.com or the SEDAR website at www.sedar.com
Andre Larente, President(450) 678-8882 ext 224
Diagnos (TSXV:ADK)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Diagnos (TSXV:ADK)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024